Gov. Tim Pawlenty's appearance at Mayo Clinic's new medical test facility next week addresses at least two core elements of the Rochester area's economic prospects for 2005. At the top of the list is ...
Pharmaceutical Technology on MSN
Klotho to acquire Turn Biotechnologies’ assets
Biogenetics company Klotho Neurosciences has announced plans to acquire certain assets from Turn Biotechnologies.
SINGAPORE, March 11, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global ...
Andrea is an editor at Game Rant, where she has been writing professionally about video games for nearly three years. She became a gamer for life at 7, thanks to a copy of Pokemon Red and her Game Boy ...
The SeQfood (Secured Quality Foods) Horizon 2020 project runs until the end of May this year. It relies on proprietary Genowas-GENOMID fingerprinting technology, a system for agrifood certification ...
Signaling no retreat from a trade dispute with Europe, President Bush on Monday sharply criticized European governments for boycotting genetically modified foods, saying their actions were impeding ...
Jacqueline Joy Battjes’ commitment to functional and regenerative medicine aligns perfectly with our mission to deliver effective, patient-focused care.” — Trace Herchman, President of GetHairMD ...
Nova BioGenetics says it was awarded a new patent using a wide array of organic compounds, replacing the currently used methanol solvent raw compound. The change to organic compound removes most all ...
GOLDEN, CO--(Marketwired - Sep 9, 2014) - iSatori, Inc. (OTCQB: IFIT), today announced the launch of their newest weight-loss innovation, called Sinetrim™, featuring patented Sinetrol®, nationally ...
Nova BioGenetics, which is preparing to execute a reverse stock split, has named a new secretary/treasurer. Todd Smith replaces Tim Moses, who will serve as president of sales for the anti-microbial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results